Abeona Therapeutics Inc (ABEO) is near the top in its industry group according to InvestorsObserver. ABEO gets an overall rating of 79. That means it scores higher than 79 percent of stocks. Abeona Therapeutics Inc gets a 90 rank in the Biotechnology industry. Biotechnology is number 13 out of 148 industries.
ABEO has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on ABEO!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 79 would rank higher than 79 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Abeona Therapeutics Inc Stock Today?
Abeona Therapeutics Inc (ABEO) stock has fallen -5.46% while the S&P 500 is higher by 0.28% as of 10:27 AM on Tuesday, Jun 6. ABEO has fallen -$0.22 from the previous closing price of $4.03 on volume of 74,639 shares. Over the past year the S&P 500 is up 3.98% while ABEO has fallen -3.30%. ABEO lost -$4.18 per share the over the last 12 months.
Click Here to get the full Stock Report for Abeona Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
